Press Releases about Relief Therapeutics Hldg Ag
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Topics
Death
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Comments on Lawsuit Filed Against It by NeuroRx
January 12, 2022
Via AccessWire
Topics
Lawsuit
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Topics
Lawsuit
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA
January 03, 2022
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Launches Level 1 ADR Program in the United States
November 18, 2021
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers
October 20, 2021
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/21211.jpg?v=1)
Via AccessWire
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.